Martin graduated in 2019 from UC Berkeley with a B.A. in Biochemistry and Molecular Biology and a B.S. in Nutritional Sciences. During his time at Berkeley, Martin worked for ENIGMA at JBEI and LBNL, a project spearheaded by Dr. Aindrila Mukhopadhyay. While working with Dr. Ankita Kothari at JBEI, Martin focused on investigating genetic and environmental factors involved in unique plasmidomes derived from groundwater.

In January of 2020, Martin joined Dr. Raffai's lab with the intent of investigating fundamental properties involved in the pathogenesis of atherosclerosis cardiovascular disease. Results of Martin’s findings contributed to numerous research publications that introduced new insights into the role of extracellular vesicles (EVS) produced by macrophages as mediators of intercellular communication in mouse models of cardiometabolic inflammation and atherosclerosis. Specifically, Martin investigated the participation of ApoE in modulating macrophage bioenergetic metabolism and the secretion of EVs with immune modulatory properties in cardiovascular inflammation. He also played a central role in studies that reported the use of alternatively activated M2-like macrophage EVs as novel biologic therapeutics for controlling systemic inflammation and insulin resistance in obese diabetic mice. More, recently Martin has been extending this line of research to investigate therapeutic properties of M2-like macrophage EVs for the control of cardiac inflammation and heart failure following a heart attack. Martin’s goal is to build on his achievements to pursue a PhD in molecular physiology and immunology, with a focus on the cardiovascular system and its related diseases.